Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Grommit who wrote (74571)	12/22/2023 12:37:34 PM
From: Madharry	Respond to of 78773

fair disclosure - there was an interesting hit piece published in the financial times on Burford., purported by an ex manager from Elliot. Some of the statements in the article were ludicrous, some may be valid. In any case the fireworks should start soon because Burford can start trying to enforce the $16 billion dollar judgement come January 10th. I was unable to copy the article or link or I would have. The most compelling arguments may be that it will difficult to enforce the judgement outside the United States and that other jurisdictions are unlikely to recognize the judgement until all the appeals are exhausted. Also there is the possibility of a sovereign default by Argentina. I took yet another beating on a biotech that had a large target price target from a brokerage company that has now dropped its price target from $75 a year ago to $1 after the company scrapped trials for their lead candidate. I am done with biotechs. Live long and prosper!